Metraipolis › archive › dc_02150cdc2661

Resistance to doxorubicin therapy in breast cancer cells could be attenuated by ligustilide: impact on autophagy and LncRNA H19 — Europe PMC PMID:42120974

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42120974
DOI
10.1186/s12906-[numero omesso]-0
License (as archived)
solo-consultazione
Archived
2026-11-02T10:12:10.890Z
SHA-256 of the archived text
fef26e7cab2bc61457f5898dc1592948cebcb327cf93dc07df6d63d805aa0231
Stable URL of this page
https://metraipolis.com/documento/dc_02150cdc2661

How to cite

Resistance to doxorubicin therapy in breast cancer cells could be attenuated by ligustilide: impact on autophagy and LncRNA H19 — Europe PMC PMID:42120974 — Europe PMC (en), https://europepmc.org/article/MED/42120974 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_02150cdc2661 (Metraipolis archive dc_02150cdc2661, sha256 fef26e7cab2bc61457f5898dc1592948cebcb327cf93dc07df6d63d805aa0231)
BibTeX
@misc{dc02150cdc2661,
  title = {Resistance to doxorubicin therapy in breast cancer cells could be attenuated by ligustilide: impact on autophagy and LncRNA H19 — Europe PMC PMID:42120974},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42120974},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_02150cdc2661; sha256 fef26e7cab2bc61457f5898dc1592948cebcb327cf93dc07df6d63d805aa0231},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42120974. Agents can read the archived copy with the MCP tool read_document.